<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biosciences Biotechnology Research Asia</journalTitle>
          <issn>0973-1245</issn>
            <publicationDate>2026-09-14</publicationDate>
    
        <volume>23</volume>
        <issue>3</issue>

 
    <startPage></startPage>
    <endPage></endPage>

	    <publisherRecordId>59694</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Advances in in vitro Tumor Models and Genetic Engineering in Cancer Research</title>

    <authors>
	 


      <author>
       <name>Dhanya Krishnan</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Gowri Priya Jayasree</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Sneha Ajilal</name>

		
	<affiliationId>2</affiliationId>
      </author>
    

	 


      <author>
       <name>Anusha Baby Satravada</name>

		
	<affiliationId>3</affiliationId>
      </author>
    


	 


      <author>
       <name>Dhamodharan Prabhu</name>

		
	<affiliationId>4</affiliationId>
      </author>
    


	 


      <author>
       <name>Ramya Ramachandran Prabhu</name>

		
	<affiliationId>1</affiliationId>
      </author>
    
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Biotechnology, CEPCI Laboratory and Research Institute, Kollam, Kerala, India</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Biotechnology, Government Arts College, Thiruvananthapuram, Kerala, India</affiliationName>
    
		
		<affiliationName affiliationId="3">Computational Oncology, Memorial Sloan Kettering Cancer Centre, New York, USA</affiliationName>
    
		
		<affiliationName affiliationId="4">Center for Bioinformatics, Department of Biotechnology, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India</affiliationName>
    
		
		
	  </affiliationsList>






    <abstract language="eng">Cancer stands as one of the leading worldwide health threats because it causes approximately 16% of all global deaths, according to the World Health Organization (WHO, 2025). This review discusses the critical role of various tissue culture techniques in studying fundamental and advanced methods used in cancer research in identifying new therapeutic targets. There are several methods to study cancer cell biology and molecular mechanisms, such as traditional two-dimensional (2D), which has long been the gold standard, and more advanced three-dimensional (3D) culture systems that better reflect molecular characteristics, cell-cell interactions, and signaling pathways. Additionally, genetic engineering tools like Clustered regularly interspaced palindromic repeats-CRISPR-associated protein 9 (CRISPR-Cas9) provide targeted genome editing and RNA interference (RNAi) based approaches such as small interfering RNAs (siRNAs) for the transient gene silencing. These genetic engineering tools offer promising models for investigating the drug response, therapeutic targets, and in cancer research.</abstract>

    <fullTextUrl format="html">https://www.biotech-asia.org/vol23no3/advances-in-in-vitro-tumor-models-and-genetic-engineering-in-cancer-research/</fullTextUrl>



      <keywords language="eng">
        <keyword>2D cultures;<strong> </strong>3D bioprinting; 3D cultures;<strong> </strong>CRISPR/Cas9;<strong> </strong>Small interfering RNAs (siRNAs)</keyword>
      </keywords>

  </record>
</records>